SOURCE: SkyLynx Communications, Inc.

March 12, 2007 15:27 ET

VETCO Hospitals, Inc. Reports Strong Sales in January

SARASOTA, FL -- (MARKET WIRE) -- March 12, 2007 -- SkyLynx Communications (OTCBB: SKYCE), a company engaged in the growth pet healthcare industry, and VETCO Hospitals, which operates 155 vaccine clinics and five full service veterinary hospitals inside of PETCO stores in five western states, announces a 17% increase in sales over 2006 figures to $512,000.

Bryan Shobe, CEO of VETCO, said, "This is significant because such increases during the typically slower months of the Pet Health sales cycle bodes well for the months to come as we head into the robust spring and summer period."

Mr. Shobe went on to say, "This is due in part to a resurgence in hospital sales and it is also reflective of the success of the joint venture with PetCareRx and the launch of internet sales from our new PetHealthRx website (www.uspethealthrx.com)."

"We've had a strong start on the New Year, and sales typically increase steadily as the year progresses, so we are extremely optimistic about the future. Our marketing agreement with PetCareRx is proving to be a key step in furthering our goals and fast-tracking our initiatives. Our remodeled website is poised to process sales efficiently at substantially increased sales volumes.

Jeanette Loeb, Co-CEO of PetCareRx, said, "We are excited to be in partnership with VETCO Hospitals, a company that shares our strong interest in providing the full range of high quality healthcare and health products for pets. We believe that this agreement will enable us to provide many more pet owners with affordable priced medications and supplements along with the convenience and service that pet owners desire. Our goal is to ensure that pets receive the quality healthcare and products at affordable prices that will enable them to live longer and healthier lives."

The American Pet Products Manufacturers estimates that 69.1 million American households, 63% of all American homes, own a pet. Spending on pets in the US is expected to reach $38.4 billon this year, up from $36.3 billion last year. Of that, vet care will account for around $9.4 billion, and supplies and OTC medicines will be $9.3 billion. In 2005, spending in both categories was $8.7 billion. APPMA's 2005-2006 National Pet Owners Survey notes that 52 percent of dogs, 24 percent of cats, 36 percent of saltwater fish, 15 percent of freshwater fish 5 percent of birds, 11 percent of small animals and 8 percent of reptiles are given medications and/or drugs.

About SkyLynx (www.skylynx.com)

SkyLynx Communications, Inc., based in Sarasota, FL, through its wholly owned subsidiary VETCO Hospitals, is building a nationwide company to create a more efficient system to deliver pet healthcare in the US. VETCO Hospitals operates 155 vaccine clinics and five (5) full service veterinary hospitals inside of PETCO stores in five (5) western states. In addition, it operates an e-service website, PetService.com and a joint venture e-commerce web site USPetHeatlhRX with PetcareRX. It intends to develop products and services for Pet Tracking, E-Commerce sales and acquiring additional veterinary hospitals within its database market.

About PetCare

PetCareRx is one of the largest online retailers of pet pharmaceuticals and supplies in North America. Founded in 1998 and based in Lynbrook, New York, PetCareRx has always been dedicated to providing pets and their owners with the medications that they need at very favorable pricing and with the highest level of customer service and convenience.

Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Contact Information

  • Contact:

    Bryan Shobe
    CEO
    941-955-1700